NCT04502160

Brief Summary

This is database designed to explore clinical outcomes related to vascular assess in the population of Northern Ireland with CKD Stage 5 and End-stage Renal Failure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 6, 2020

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2024

Completed
Last Updated

April 21, 2022

Status Verified

April 1, 2022

Enrollment Period

4.4 years

First QC Date

August 4, 2020

Last Update Submit

April 14, 2022

Conditions

Hemodialysis Access FailureArteriovenous Fistula

Outcome Measures

Primary Outcomes (1)

  • Rates of Arteriovenous Fistula Failure to Mature

    Rates of Arteriovenous Fistula Failure to Mature

    1 year

Interventions

Vascular Access CreationPROCEDURE

arteriovenous fistula creation

Also known as: arteriovenous fistula creation

Eligibility Criteria

Age16 Years - 105 Years
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Individuals undergoing AVF creation between January 2009 and December 2020 in a single centre (Belfast City Hospital

You may qualify if:

  • Individuals attending Nephrology undergoing AVFcreation between January 2009 and December 2019 in a single centre (Belfast City Hospital

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Belfast City Hospital

Belfast, Antrim, BT9 7AB, United Kingdom

RECRUITING

MeSH Terms

Conditions

Arteriovenous Fistula

Condition Hierarchy (Ancestors)

Arteriovenous MalformationsVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular FistulaVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesFistulaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Jennifer Hanko

    Belfast Health and Social Care Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Agnes Masengu

CONTACT

0289043819agnes.masengu@belfasttrust.hscni.net

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2020

First Posted

August 6, 2020

Study Start

June 15, 2020

Primary Completion

October 22, 2024

Study Completion

October 22, 2024

Last Updated

April 21, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Would require application to Belfast Health and Social Care Trust Research and Development office

Locations

GB(1)